FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway
- 14 May 2020
- journal article
- research article
- Published by Elsevier BV in Experimental and Molecular Pathology
- Vol. 115, 104451
- https://doi.org/10.1016/j.yexmp.2020.104451
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?The Oncologist, 2016
- Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphomaBiomedicine & Pharmacotherapy, 2016
- Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancerEuropean Journal of Cancer, 2015
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotypeScientific Reports, 2015
- The Wnt/β-catenin pathway in ovarian cancer: A reviewGynecologic Oncology, 2013
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma TumorigenesisCancer Cell, 2011
- Chemical-Genetic Screen Identifies Riluzole as an Enhancer of Wnt/β-catenin Signaling in MelanomaCell Chemical Biology, 2010
- Molecular Pathogenesis of Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2005
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE: RESULTS WITH COMBINATION CHEMOTHERAPYThe Lancet, 1975